Celularity Inc (CELU)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 7M 14M 21M Q1 '21: 2.7M Q2 '21: 3.2M Q3 '21: 10.6M Q4 '21: 4.9M Q1 '22: 5.9M Q2 '22: 3.8M Q3 '22: 4.1M Q4 '22: 4.1M Q1 '23: 3.9M Q2 '23: 2.9M Q3 '23: 3.8M Q4 '23: 12.1M Q1 '24: 14.7M Q2 '24: 12.1M Q3 '24: 9.3M Q4 '24: 18.1M Q1 '25: 11.4M Q2 '25: 5.7M Q3 '25: 5.3M Q4 '25: 4.1M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Gross Profit Quarterly

-6M -3M 0 3M 6M 9M Q3 '20: 2.3M Q4 '20: 2.1M Q1 '21: 1.4M Q2 '21: 1.8M Q3 '21: 8.3M Q4 '21: 196K Q1 '22: 1.9M Q2 '22: 597K Q3 '22: -3.1M Q4 '22: -1.1M Q1 '23: 1.9M Q2 '23: 2.1M Q3 '23: 184K Q4 '23: 2.5M Q4 '20 Q2 '21 Q4 '21 Q2 '22 Q4 '22 Q2 '23 Q4 '23

Operating Income Quarterly

-105M -70M -35M 0 35M 70M 105M Q1 '21: -44.4M Q2 '21: -60.6M Q3 '21: 10.9M Q4 '21: -15M Q1 '22: -41.6M Q2 '22: 4.2M Q3 '22: -5.6M Q4 '22: 17.5M Q1 '23: -63.9M Q2 '23: -42.5M Q3 '23: -99.3M Q4 '23: 13.3M Q1 '24: -7.4M Q2 '24: -10.2M Q3 '24: -11.5M Q4 '24: -9.3M Q1 '25: -10.5M Q2 '25: -15.9M Q3 '25: -12.9M Q4 '25: -22.1M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Net Income Quarterly

-105M -70M -35M 0 35M 70M 105M Q1 '21: -81.5M Q2 '21: -64.5M Q3 '21: 49.9M Q4 '21: -4M Q1 '22: -62.9M Q2 '22: 47.8M Q3 '22: 4.8M Q4 '22: 24.4M Q1 '23: -64M Q2 '23: -47.9M Q3 '23: -93.9M Q4 '23: 9.5M Q1 '24: -22M Q2 '24: -6.5M Q3 '24: -16.1M Q4 '24: -13.3M Q1 '25: -19.8M Q2 '25: -24.5M Q3 '25: -23.1M Q4 '25: -24.4M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Cost of Revenue Quarterly

0 3.5M 7M 10.5M Q1 '23: 2M Q2 '23: 802K Q3 '23: 3.6M Q4 '23: 9.6M Q1 '24: 1.6M Q2 '24: 2.1M Q3 '24: 3.9M Q4 '24: 7.3M Q1 '25: 3.6M Q2 '25: 5.2M Q3 '25: 3.9M Q4 '25: 7.4M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '21: -25.1M Q2 '21: -18.2M Q3 '21: -34.8M Q4 '21: -32M Q1 '22: -34.3M Q2 '22: -36.3M Q3 '22: -37.7M Q4 '22: -29.6M Q1 '23: -15M Q2 '23: -11M Q3 '23: -8.3M Q4 '23: -4.3M Q1 '24: -4.4M Q2 '24: -3.4M Q3 '24: -144K Q4 '24: 1.6M Q1 '25: -3M Q2 '25: -999K Q3 '25: -4.2M Q4 '25: -5.1M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q4 '20: -26.2M Q1 '21: -26.6M Q2 '21: -19.5M Q3 '21: -35.9M Q4 '21: -34.3M Q1 '22: -35.7M Q2 '22: -37.8M Q3 '22: -39.3M Q4 '22: -30.4M Q1 '23: -15.2M Q2 '23: -11.1M Q3 '23: -8.6M Q4 '23: -4.9M Q1 '24: -4.4M Q2 '24: -3.5M Q3 '24: -144K Q4 '24: 1.5M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 60M 120M 180M Q3 '20: 18.4M Q2 '21: 24M Q3 '21: 123.6M Q1 '22: 130.4M Q2 '22: 151.3M Q3 '22: 150.5M Q1 '23: 15.5M Q2 '23: 17.7M Q3 '23: 18.8M Q1 '24: 21.4M Q2 '24: 21.8M Q3 '24: 22M Q1 '25: 23.5M Q2 '25: 24M Q3 '25: 26.3M Q3 '20 Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-21.00 -14.00 -7.00 0.00 7.00 14.00 21.00 Q1 '21: -17.18 Q2 '21: -19.87 Q3 '21: -16.95 Q4 '21: -1.49 Q1 '22: 1.43 Q2 '22: 4.44 Q3 '22: 4.07 Q4 '22: 0.89 Q1 '23: -2.75 Q2 '23: -5.79 Q3 '23: -10.80 Q4 '23: -11.02 Q1 '24: -7.93 Q2 '24: -5.51 Q3 '24: -1.26 Q4 '24: -2.65 Q1 '25: -2.46 Q2 '25: -3.18 Q3 '25: -3.33 Q4 '25: -3.59 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.